A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
This is a Phase 1, double-blind, sponsor-unblinded, randomized, placebo-controlled study designed to characterize the safety, tolerability, and PK of JZP047 in healthy participants following single-ascending doses of study intervention. Additionally, the effect of food on PK following a single dose of JZP047 will be assessed through comparison of PK between the fed and fasted states.
Key facts
- Study ID
- NCT07377539
- Run by
- Jazz Pharmaceuticals
- People needed
- 86
- Starts
- 2026-02-03
- Expected to finish
- 2026-07-05
- Last updated by the study team
- 2026-04-20
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion, Inc. — Lincoln, Nebraska, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.